1. The short-and long-term effects of oral phosphate supplements were studied in two groups of adult rabbits.
Segal, 1967), Paget's disease (Benson, Goldsmith, Ingbar, Abelmann & Braverman, 1967) and multiple myeloma (Goldsmith, Bartos, Hulley, Ingbar & Moloney, 1968) . Phosphates have also been used in the treatment of fracture healing . A frequent finding has been a decrease in both the serum concentration and urinary excretion of calcium (Dent, 1962; Goldsmith & Ingbar, 1966b; Pak et al., 1968) . The decreased urinary excretion of calcium was often associated with calcium retention, measured by calcium-balance studies. As a result of these observations and the apparent changes in bone in some instances, it has been concluded that phosphate supplements have a direct action on bone metabolism and result in either increased bone accretion or decreased bone resorption (Goldsmith & Ingbar, 1966a ). This conclusion has been supported by a number of studies in intact experimental animals Pechet, Bobadilla, Carroll & Hesse, 1967) as well as by tissue culture studies (Raisz & Niemann, 1969) ; however, the observations have been indirect.
It has recently been suggested (Goldsmith, 1970; Stamp, 1971 ) that oral phosphate supplements be used for the treatment of metabolic bone disease. In view of the controversial literature which suggests that a high phosphate intake causes increased resorption of bone (Kintner & Holt, 1932; Krook, Barrett, Usui & Wolke, 1963; Krook & Lowe, 1964) , we thought that the effect of orally administered phosphate on bone should be examined. In particular, two questions should be answered. (1) What is the effect of phosphate on bone formation and resorption? (2) What is the site of retention of calcium in the various tissues of the body? The present study was designed to examine in rabbits the effect of oral phosphate supplementation on bone remodelling and calcium deposition in soft tissue and to re-evaluate the use of this treatment for bone disorders.
M E T H O D S
Adult white rabbits weighing between 2.5 and 3.5 kg were used throughout the study; closure of the epiphyses at the knee was taken as an indication of age.
Short-term studies
Seventeen rabbits were fed a control diet of Purina rabbit chow for 10 days (Table 1) . At the end of this control period the rabbits were anaesthetized and defects were made with an electric saw in the upper end of both tibias in each rabbit. The defect consisted of a horizontal slit, 5 mm long and 2 mm wide, extending from the medial surface to the inner half of the posterior surface of the anterior tuberosity and was limited posteriorly by the popliteal line of the tibia. The periosteum was disturbed as little as possible; no immobilization was attempted and no rabbit included in the study developed a complete fracture of the tibia. Immediately after creation of the defect, the rabbits were divided into two groups; eight control rabbits were continued on the rabbit chow and nine rabbits were fed the same amount of chow with added potassium dihydrogen phosphate and disodium hydrogen phosphate (Table 1) . Four control and four phosphate-supplemented animals were killed at the end of 4 weeks and the remainder were killed at the end of 8 weeks.
Long-term studies
Twelve rabbits were fed a control diet of Omolene (Ralston Purina, St Louis, Mo., U.S.A.) for a control period of 10 days (Table 1) . Six rabbits were then continued on this diet and six animals were fed Omolene plus bran. The animals were killed at the end of 6 months. The phosphate supplement in this group corresponded on a weight basis to the amounts of phosphate used in man.
Serum calcium and phosphate
Fasting morning blood was drawn in both groups before the phosphate was added to the diet. In the short-term study additional fasting blood samples were drawn at 3, 4, 7 and 8 "Sr uptake These studies were performed to evaluate the mineral distribution in the body. In the shortterm study 85Sr uptake was evaluated at the end of 8 weeks in eight rabbits (four control and four phosphate-supplemented). In the long-term study "Sr uptake was measured in six control and five phosphate-supplemented rabbits at the end of 6 months. For this measurement 50 pCi of [85Sr]strontium chloride was injected intravenously into the marginal ear vein. Immediately after the injection the initial body content of 85Sr was measured by using a smallanimal counter equipped with a sodium iodide crystal. The total body retention of 85Sr was again measured on day 5 and the percentage of the initial body content was calculated for each rabbit. Blood samples (1 ml) were withdrawn with a heparinized syringe 1, 4 and 8 h after injection of 85Sr on day 1, at 9.00 a.m. and 2.00 p.m. on days 2, 3 and 4 and at 9.00 a.m. on day 5. Of each blood sample 0.5 ml was pipetted into a plastic tube containing 0.5 ml of water, and the 85Sr radioactivity was counted in a well-type scintillation counter. At the time the rabbits were killed, tissue samples were taken from the kidney, liver, heart, skeletal muscle and thoracic and abdominal aorta. A 1 cm long piece of bone from the distal femur shaft was taken as a sample of cortical bone. Fat was extracted from the tissue and bone samples with an ether-acetone mixture. The soft-tissue samples were then freeze-dried in solid COz and powdered; 200 mg of tissue was placed in plastic tubes and the 85Sr radioactivity was counted. The fat-free dry bone was weighed and dissolved in 5 ml of conc. HCl.
This solution was then diluted with 5 ml of water. An estimation of 8 5 Sr was made in 0.1 ml of the diluted solution. The results were expressed in terms of the total spectrum c.p.m. per 100 mg of dry fat-free weight of tissue or bone.
In the long-term group the calcium content was measured in the samples of soft tissue and bone used for measurement of '%r. Weighed amounts of dry fat-free tissue were dissolved in 5 ml of conc. HCl and the calcium content of 1 ml of this solution was determined by atomic absorption spectrophotometry. The weight of calcium per unit weight of dry fat-free tissue was calculated for each sample.
Histo logy
In each rabbit a detailed post-mortem examination was made of the viscera of the abdomen and thorax. Samples of kidney, liver, heart, aorta, small intestine and skeletal muscle were taken for histologic study and stained with haematoxylin and eosin and also with the von Kossa stain.
Porosity of bone in femur and tibia
In each rabbit of the short-term group both tibias (with their defects) and the right femur were removed at the time of death. In the long-term group the right tibia and right femur were removed. The bones were fixed in alcohol and sections were cut from the midshaft of the femurs and the proximal tibial metaphysis in both groups and from the defect site and from a site 1 cm distal to the defect in the short-term group. The area of cortical bone was measured by planimetry. In the tibial defect samples the cortical spaces were counted on enlarged positive prints of three sections from both tibias from each rabbit. The total area of the cortical spaces, in mm2/100 mm2 of cortical bone, was determined in each section. In the intact femurs and tibias counts were made of the number of holes (which were of a relatively uniform size) in the area of the cortex between the periosteum and endosteum. The area of the cortex was similar in all animals. The porosity values were obtained from three sections and the mean number of holes per section and mean area per section were calculated.
R E S U L T S

Short-term study
The control group showed no weight change; however, the phosphate-supplemented animals showed a mean weight loss of 0.5 kg by the end of the 8 week period. Possibly because of the small number of animals, this proved not to be significant (P> 0-05). One phosphate-supplemented rabbit died at the end of 4 weeks with mucous diarrhoea 5 days before death; postmortem examination showed congestion of the large intestine and subcapsular petechial haemorrhages in both kidneys. A second phosphate-supplemented rabbit died at the end of 7 weeks with a similar history; in addition there was a perforation of the ileum near the ileocaecal junction. The data from these rabbits were not included in the '%r evaluation.
The serum phosphate concentrations increased significantly whereas the serum calcium values decreased by a small but significant amount ( Table 2 ). The activity of 85Sr in the blood (Table 3 ) decreased with time but was consistently higher in the phosphate-supplemented rabbits from 8 h after injection until they were killed. The total body retention of "Sr was higher in the phosphate-supplemented rabbits compared with controls and this was reflected in the bone and soft-tissue samples, particularly in the kidney and thoracic aorta ( Table 4) .
The calcium content was measured only in the thoracic aorta in this study; at 8 weeks the mean values were 25 pg/lOO mg of dry fat-free weight in four control animals and 24 660 pg/lOO mg in four phosphate-supplemented animals.
Histologic evidence of soft-tissue calcification was seen in the cortex of the kidney, accompanied by disruption of the glomeruli (Fig. 1) of rabbits killed at 4 and at 8 weeks. In the aorta calcified deposits were seen in the media in all rabbits killed at 8 weeks (Fig. 2) ; those killed at 4 weeks showed disruption of the fibres of the media only. The measurements of porosity are shown in Table 5 . In the phosphate-supplemented animals the porosity was increased both in the defect site in the tibia (Fig. 3) and in the old bone adjacent to the defect site (Fig. 4) . In addition, the number of resorption cavities or holes per section in the femur was significantly higher although there was no difference in the area of the bone.
Long-term study
At the end of the 6 month period the control animals had lost an average of 0.4 kg (P<O.O5) and the phosphate-supplemented animals had lost 0-5 kg (P<O-OI). Otherwise, all animals appeared to be in good health. The serum calcium decreased in both groups but the change was For difference from control, *P < 005 ; t P < 0.02 ; $P -= 0.005 ; §P < 0.001. For difference from control, t P < 0.05 ; $ P i 0.005; § P i 0001.
significant only in the phosphate-supplemented animals ( Table 2 ). There was no significant change in serum phosphate. The disappearance of *'Sr from the blood after injection was slower in the phosphatesupplemented animals, the amount of radioactivity being higher from 8 h after injection of the isotope until day 5 ( Table 3) . The total body retention at 5 days was higher and the retention of *%r in the tissues was also higher as a result of phosphate supplementation,; however, of the soft-tissue samples only the kidney showed a statistically higher value ( Table 6) . The values for the calcium content of these tissues were higher in the phosphate-supplemented group but not significantly so except in the abdominal aorta. No histologic evidence of abnormal calcification was seen in any of the soft tissues of the animals in the long-term study. Cortical bone porosity was increased as a result of the phosphate supplementation in both the femur and the tibia (Table 5 ). The number of holes per section was 6-12 times higher than in controls (Fig. 5) . In the femur there was no loss of cross-sectional area, implying that the periosteal and endosteal surfaces had not undergone resorption ; however, in the cortical samples from the metaphysis of the tibia there was a decrease in the cross-sectional area of bone. The area decreased to approx. 87% of the control value whereas the number of holes increased by 530%; increase in the number of holes per section therefore represents a real increase in porosity of the bone.
D I S C U S S I O N
It has been firmly established that both orally (Albright et al., 1932; Dent, 1962) and intravenously (Goldsmith & Ingbar, 1966b; Eisenberg, 1970 ) administered phosphate will result in a decrease of the serum calcium in both hypercalcaemic and normocalcaemic persons. Since the urinary excretion of calcium is consistently decreased, it is not surprising to find that phosphate will cause a marked increase in the body retention of calcium. In the present study at both high and low amounts of oral phosphate supplementation there was a clear increase in the retention of "Sr, which indicated mineral retention by the body. The site of mineral deposition within the body still remains partially uncertain. In man extraskeletal calcification has frequently been reported to result from intravenous phosphate infusions (Goldsmith & Ingbar, 1966b; Hebert, Lemann, Petersen & Lennon, 1966; Breuer & LeBauer, 1967; Carey, Schmitt, Kopald & Kantrowitz, 1968) ; it is less frequently seen as a consequence of oral phosphate supplements (Dent et al., 1964; Dudley & Blackburn, 1970; Stamp, 1971) . These findings in man rely on gross or roentgenologic demonstration of calcium deposits. In animals it has been possible to measure the amount of calcium in the soft tissues at concentrations below those at which X-ray evidence of calcification occurs. In rats with vitamin D-induced hypercalcaemia oral phosphate supplementation has resulted in increased calcium content of heart and kidney tissue (Spaulding & Walser, 1970) . Kidney calcification has also been documented in humans undergoing phosphate infusion treatment for hypercalcaemia (Breuer & LeBauer, 1967; Carey et al., 1968) . Since hypercalcaemia has been considered to be an adequate explanation of extraskeletal calcium in man (Kahil, Orman, Gyorkey & Brown, 1967; Thalassinos & Joplin, 1968) , it is important to document the occurrence of calcium deposits in normocalcaemic animals. The majority of such reports describe renal calcification (Craig, 1959 ; Hamuro, Shino & Suzuoki, 1970) or parathyroid hormone-induced changes in the kidney (MacKay & Oliver, 1935; McFarlane, 1941) . These studies were in rats. In rabbits the same changes occur and an increase in mineral content was seen in the presence of normocalcaemia at both levels of phosphate supplementation. However, only at high levels of supplementation which caused hyperphosphataemia, was this accompanied by histologic evidence of calcium deposition.
An additional site of calcification resulting from phosphate supplementation was the aorta. In the high-level supplementation group there was an increase of mineral retention greater than that seen in other tissues. That the lower amount of supplementation increased aortic calcification was suggested by the increased calcium content. The mean '%r retention was higher but individual variation between rabbits prevented the difference from being statistically significant. It is perhaps relevant that the aorta is a common site of pathological calcification in man.
The finding of increased calcium content of soft tissues would therefore indicate that the retained calcium is precipitated, most probably by the mechanism suggested and described by Gersh (1937) and Hebert et al. (1966) .
Since the reports by Reiss, Canterbury, Bercovitz & Kaplan (1970) and Reiss & Canterbury (1971) that oral phosphate supplementation in both man and dogs produced an increase in circulating immunoreactive parathyroid hormone (IPTH), it has become evident that phosphate may affect bone turnover through a stimulation of secretion of this hormone. The bone change in the present study, an increase in porosity, was marked when bone remodelling was accelerated. The decrease in total calcium that followed phosphate supplementation in the study by Reiss et al. (1970) was accompanied by an increase in serum phosphate and a decrease in ionized calcium which presumably caused the increase in IPTH. In our study, a decrease in serum calcium occurred at both levels of phosphate supplementation, which makes it likely that the increased bone resorption was mediated through increased parathyroid hormone concentrations.
In view of the previous reports of secondary hyperparathyroid bone disease produced in animals by a high phosphate intake, it is perhaps not surprising to see increased porosity in the rabbits reported here. However, in the previous studies the increased phosphate intake was accompanied by a decreased calcium intake, and it is possible that calcium deficiency alone may have produced the changes. However, we have been able to show that it is an excess of phosphate over calcium that is important. In the long-term study although the control group was maintained on a low calcium intake, the Ca/PO, ratio was still about 1 and the bone showed little evidence of resorption or porosity. The addition of phosphate in relatively small amounts, but enough to decrease the Ca/PO, ratio to about 0.5, resulted in an increase in resorption and porosity. In the short-term study the control group had a high calcium intake and a Ca/PO, ratio greater than 1 ; when this ratio was decreased to about 0.5, the bones showed increased porosity even though the animals continued the same high calcium intake.
It may be incorrect to use the information derived from this study in rabbits to draw conclusions concerning the effect of dietary calcium and phosphate in man. However, it is permissible to compare the results of this study with findings in man. In inhabitants of North America the average phosphate intake is higher than the average calcium intake. In a group of thirty osteoporotic patients studied here, the mean estimated phosphate intake was 1219 mg/day whereas the mean calcium intake was 743 mg/day (P<0.0005). In a smaller group, when bone resorption was plotted against the daily phosphate intake, a positive correlation was obtained (r = 0.68; P<0-03) (Jowsey unpublished work) . In four patients circulating IPTH correlated well with bone resorption (Jowsey, Riggs, Goldsmith, Kelly & Arnaud, 1972) . The sequence of events described by Reiss & Canterbury (1971) for early renal hyperparathyroidism may hold for an increased dietary intake of phosphate. These authors postulated that 'transient hyperphosphatemia induces hypocalcemia which in turn stimulates PTH secretion.' In man this sequence has been partially demonstrated; in animal studies we lack only the assay of IPTH.
The increased porosity of the bone in and adjacent to the fracture site in the short-term study suggested that the effect of phosphate supplements here, as elsewhere in the skeleton, was to produce increased resorption of bone. It is doubtful if this would consistently improve fracture healing rate above normal.
